appointed Mr. Anton du Plessis as new Chief Executive Officer today., the European focused mineral exploration company,
Mr. du Plessis has over 20 years’ experience in the finance sector, with a focus on advising natural resources companies on the execution of strategic and financing transactions.
He has held senior positions at several international investment banks including CIBC (The Canadian Imperial Bank of Commerce), Bank of America Merrill Lynch and Morgan Stanley.
Mr. du Plessis has a proven track record across a range of commodities, working on transactions for a number of leading global players including Anglogold Ashanti,and .
Jeremy Martin, Chairman of Erris Resources, commented: “Attracting someone of Anton's calibre, with a track record of advising leading mining companies, will be a positive addition to the team.”
The appointment follows the resignation of Merlin Marr-Johnson as a director of the Company, also today, who has elected to step down to pursue other business interests.
“He has invaluable specialist knowledge, experience and a wealth of international industry contacts, which will be of particular value as we work to build the value in Erris Resources through the development of our asset portfolio and its strategy to identify high value opportunities."
Erris Resources has an established portfolio of zinc assets in Ireland and gold projects in Sweden, with support and financial backing from major Canadian mining majors including Osisko Gold Royalties and TSX listed Centerra Gold.
SP Angel morning look at commodities and miners, featuring: Anglo Asian Mining (AAZ LN) BUY – 96p (from 108p) – Earnings update Glencore (GLEN LN) – Glencore claim record EBITDA on strong copper mine performance Landore Resources (LND LN) – BAM Gold Preliminary Economic Assessment Pan African Resources (PAF LN) – Earnings climb as operations refocus on profitable ounces Transense Technologies plc (TRT LN) – 2nd mining contract announced this week for mining heavy truck tracking & tyre pressure monitoring
In a conference call to investors and analysts, Motif Bio confirmed that the FDA had no questions over the clinical efficacy of Iclaprim. However the FDA stated it needs additional data to further evaluate the risk for liver toxicity before the NDA approval.
Five financial stories, trending today in a 70 second podcast, including: The number of people in work in the UK has continued to climb, with a record 32.6 million employed between October and December The jobless rate, remaining at 4%, is at its lowest since early 1975.
On today's podcast: Xpediator discuss their trading update which saw a 54% increase in evenues to approximately £179 million. TMT Investments #TMT discusses their strategy which is to invest in high-growth, internet-based companies. Alan Green covers The AA, Europa Oil & Gas & RA International.
SP Angel morning look at commodities and miners, featuring: Asiamet Resources (ARS LN) – BKM resource drilling ARC Minerals* (ARCM LN) – £2.2m funding BHP Billiton (BHP LN) - H1 results Patagonia Gold (PGD LN) – Closure of Lomada de Leiva and Cap Oeste Strategic Minerals* (SML LN) – Exercise of options Talga Resources* (TLG AU) – Further gains from Talga high energy battery anode product